145 related articles for article (PubMed ID: 2425171)
21. Time course of the metabolite patterns of intraventricularly injected [3H]noradrenaline in rat brain regions.
Köster G
J Neurochem; 1986 Oct; 47(4):1132-40. PubMed ID: 3746298
[TBL] [Abstract][Full Text] [Related]
22. Errors introduced by a tritium label in position 8 of catecholamines.
Grohmann M; Henseling M; Cassis L; Trendelenburg U
Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan; 332(1):34-42. PubMed ID: 2419773
[TBL] [Abstract][Full Text] [Related]
23. Ramiprilat attenuates the local release of noradrenaline in the ischemic myocardium.
Carlsson L; Abrahamsson T
Eur J Pharmacol; 1989 Jul; 166(2):157-64. PubMed ID: 2792189
[TBL] [Abstract][Full Text] [Related]
24. The effect of desipramine on ischemia-induced changes in extracellular K+, Na+, and H+ concentrations and noradrenaline release in the isolated rat heart during global ischemia.
Knopf H; Theising R; Hirche H
J Cardiovasc Pharmacol; 1988; 12 Suppl 1():S8-14. PubMed ID: 2468840
[TBL] [Abstract][Full Text] [Related]
25. Nonexocytotic noradrenaline release and ventricular fibrillation in ischemic rat hearts.
Kurz T; Offner B; Schreieck J; Richardt G; Tölg R; Schömig A
Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):491-6. PubMed ID: 8751077
[TBL] [Abstract][Full Text] [Related]
26. Reduction of tissue noradrenaline content in the isolated perfused rat heart during ischemia: importance of monoamine oxidation.
Lamontagne D; Yamaguchi N; Ribuot C; de Champlain J; Nadeau R
Can J Physiol Pharmacol; 1991 Aug; 69(8):1190-5. PubMed ID: 1782601
[TBL] [Abstract][Full Text] [Related]
27. The disposition of 3H-(--)noradrenaline in the perfused cat and rabbit heart.
Graefe KH
Naunyn Schmiedebergs Arch Pharmacol; 1981 Dec; 318(2):71-82. PubMed ID: 7329455
[TBL] [Abstract][Full Text] [Related]
28. Impairment of the extraneuronal O-methylating system of isoproterenol by stop-flow ischemia in the perfused rat heart.
Inoue M; Hifumi K; Kurahashi K; Fujiwara M
J Pharmacol Exp Ther; 1987 Sep; 242(3):1086-9. PubMed ID: 3656108
[TBL] [Abstract][Full Text] [Related]
29. Possible physiological significance of the initial step in the catabolism of noradrenaline in the central nervous system of the rat.
Farah MB; Adler-Graschinsky E; Langer SZ
Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(2):119-31. PubMed ID: 585416
[TBL] [Abstract][Full Text] [Related]
30. Neuronal and extraneuronal uptake of 3H-noradrenaline in rat portal vein in vitro.
Hedner J; Almgren O; Jonason J; Lundberg D
Acta Physiol Scand; 1981 Feb; 111(2):171-7. PubMed ID: 7282392
[TBL] [Abstract][Full Text] [Related]
31. Nonexocytotic release of endogenous noradrenaline in the ischemic and anoxic rat heart: mechanism and metabolic requirements.
Schömig A; Fischer S; Kurz T; Richardt G; Schömig E
Circ Res; 1987 Feb; 60(2):194-205. PubMed ID: 3568291
[TBL] [Abstract][Full Text] [Related]
32. The effect of inhibitors of extraneuronal uptake on the distribution of 3H-(+/-)noradrenaline in nerve-free rabbit aortic strips.
Eckert E; Henseling M; Trendelenburg U
Naunyn Schmiedebergs Arch Pharmacol; 1976 May; 293(2):115-27. PubMed ID: 958502
[TBL] [Abstract][Full Text] [Related]
33. Extraneuronal inactivation of noradrenaline in tissue culture.
Schömig E; Babin-Ebell J; Gliese M; Russ H
J Neural Transm Suppl; 1991; 34():43-9. PubMed ID: 1817163
[TBL] [Abstract][Full Text] [Related]
34. Release of [3H]noradrenaline from perfused rat hearts by potassium and its modifications by 6-hydroxydopamine and reserpine.
Carpenter JR; Nash CW
Can J Physiol Pharmacol; 1976 Dec; 54(6):907-15. PubMed ID: 1021224
[TBL] [Abstract][Full Text] [Related]
35. Nicotine receptors do not modulate the 3H-noradrenaline release from the isolated rat heart evoked by sympathetic nerve stimulation.
Fuder H; Siebenborn R; Muscholl E
Naunyn Schmiedebergs Arch Pharmacol; 1982 Mar; 318(4):301-7. PubMed ID: 7078664
[No Abstract] [Full Text] [Related]
36. Effects of yohimbine and desipramine on cardiac noradrenaline release and ventricular arrhythmias during acute coronary artery occlusion and reperfusion in anesthetized dogs.
Yamaguchi N; Lamontagne D; Boudreau G; Nadeau R; de Champlain J
Can J Physiol Pharmacol; 1987 Nov; 65(11):2244-53. PubMed ID: 3449186
[TBL] [Abstract][Full Text] [Related]
37. Neuronal efflux of noradrenaline induced by tris or lithium as substitutes for extracellular sodium.
Bönisch H; Langeloh A
Naunyn Schmiedebergs Arch Pharmacol; 1986 May; 333(1):13-6. PubMed ID: 3016559
[TBL] [Abstract][Full Text] [Related]
38. Disposition of endogenous adrenaline compared to noradrenaline released by cardiac sympathetic nerves in the anaesthetized dog.
Eisenhofer G; Smolich JJ; Esler MD
Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):160-71. PubMed ID: 1570020
[TBL] [Abstract][Full Text] [Related]
39. The heterogeneity of the neuronal distribution of exogenous noradrenaline in the rat vas deferens.
Schömig E; Schönfeld CL; Halbrügge T; Graefe KH; Trendelenburg U
Naunyn Schmiedebergs Arch Pharmacol; 1990 Aug; 342(2):160-70. PubMed ID: 2234101
[TBL] [Abstract][Full Text] [Related]
40. Effects of increased heart work on release of norepinephrine and ventricular arrhythmias following reperfusion in the isolated rat heart.
Moreau D; Rochette L; Didier JP; Opie LH; Bralet J
J Cardiovasc Pharmacol; 1990 Jun; 15(6):927-32. PubMed ID: 1694915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]